Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Mikhael

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Blood|August 30, 2011
Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphomaRobert Griffiths, Joseph Mikhael, Michelle Gleeson, et al.
Journal of Cancer Epidemiology|September 13, 2012
Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-MedicareRobert I Griffiths, Michelle L Gleeson, Joseph Mikhael, et al.
American Journal of Hematology|August 26, 2009
Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpuraMark D Danese, Karla Lindquist, Michelle Gleeson, et al.
American Journal of Hematology|August 29, 2009
Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: a systematic reviewJoseph Mikhael, Kelly Northridge, Karla Lindquist, et al.
Leukemia Research|August 23, 2021
Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatmentKrisstina Gowin, Sheri Skerget, Jonathan J Keats, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Practical Considerations for Antibodies in MyelomaJacob P Laubach, Niels van de Donk, Faith E Davies, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 25, 2009
Resident preparedness in discussing prognosis in patients with advanced lung cancerPaul Wheatley-Price, Christine Massey, Tony Panzarella, et al.
Blood Cancer Journal|December 15, 2017
Correlation between markers of bone metabolism and vitamin D levels in patients with monoclonal gammopathy of undetermined significance (MGUS)Brea Lipe, Suman Kambhampati, Peter Van Veldhuizen, et al.
Blood Cancer Journal|March 31, 2019
Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myelomaThomas Martin, Stephen Strickland, Martha Glenn, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 22, 2011
The blue man: a novel cutaneous manifestation of systemic amyloidosisMark Campbell, Allison Rosenthal, Madappa Kundranda, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Blood|August 30, 2011
Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphomaRobert Griffiths, Joseph Mikhael, Michelle Gleeson, et al.
Journal of Cancer Epidemiology|September 13, 2012
Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-MedicareRobert I Griffiths, Michelle L Gleeson, Joseph Mikhael, et al.
American Journal of Hematology|August 26, 2009
Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpuraMark D Danese, Karla Lindquist, Michelle Gleeson, et al.
American Journal of Hematology|August 29, 2009
Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: a systematic reviewJoseph Mikhael, Kelly Northridge, Karla Lindquist, et al.
Leukemia Research|August 23, 2021
Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatmentKrisstina Gowin, Sheri Skerget, Jonathan J Keats, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Practical Considerations for Antibodies in MyelomaJacob P Laubach, Niels van de Donk, Faith E Davies, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 25, 2009
Resident preparedness in discussing prognosis in patients with advanced lung cancerPaul Wheatley-Price, Christine Massey, Tony Panzarella, et al.
Blood Cancer Journal|December 15, 2017
Correlation between markers of bone metabolism and vitamin D levels in patients with monoclonal gammopathy of undetermined significance (MGUS)Brea Lipe, Suman Kambhampati, Peter Van Veldhuizen, et al.
Blood Cancer Journal|March 31, 2019
Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myelomaThomas Martin, Stephen Strickland, Martha Glenn, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 22, 2011
The blue man: a novel cutaneous manifestation of systemic amyloidosisMark Campbell, Allison Rosenthal, Madappa Kundranda, et al.
Pageof 11